Boehringer recently reported positive results from the Beamion LUNG-1 trial evaluating zongertinib in treatment-naïve patients with advanced NSCLC at ESMO 2025. The company is pursuing regulatory ...
New deal builds on the success of a longstanding partnership in retinal health and the potential of CDR-Life’s unique antibody fragment-based platform Agreement provides potential for up to approx.
The Sixers couldn’t fully dig themselves out of an early hole and dropped their first game of the season to the Celtics.
Tuned in to watch the Boston Celtics and the Philadelphia 76ers battle it out for some NBA Cup action, The Ringer’s Bill ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback